Lab QC by Risk Management
MedSun: Newsletter #58, March 2011

ADVANCE for Laboratory Administrators

The draft CLSI guidelines will assist labs in choosing control processes for test hazards. EP22 is intended for manufacturers and describes device hazards and possible control processes and their effectiveness to reduce risk. EP23 is intended for labs and discusses manufacturer information, local regulations and lab settings to customize QC plans. Once implemented, EP23 will guide monitoring/modification for continuous quality improvement when new hazards are identified.

Additional Information:

Lab QC by Risk Management. ADVANCE for Laboratory Administrators. May 6, 2010.
http://laboratory-manager.advanceweb.com/Features/Article-1/Lab-QC-by-Risk-Management.aspx


MedSun Newsletters are available at www.fda.gov/cdrh/medsun